Drug intelligence / Profile preview

DHEP II

Development stage: Unknown
Lead developer: Jiangsu Provincial Hospital of Traditional Chinese Medicine
Administration: Rectal

Overview

DHEP II is an herbal enema prescription being investigated for its efficacy in the treatment of mild or moderate active symptoms of ulcerative colitis. It is typically administered as an enema and has been studied in combination with Mesalazine in clinical trials.

Other names: Herbal enema prescriptionII溃结灌肠液Ⅱ

Beyond the preview

Go deeper on DHEP II.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on DHEP II.

Explore the full profile